DatasetName,MAPK1IP1L_S(15) MAPK1IP1L_S(2),MAPK1IP1L_S(6)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.49922339360384027,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),0.488386813763785,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,0.6993890422104292,0.508887385880861
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.6324039738556356,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5171018326720567,
RKK2015_TNF-α/basal,0.40723494785255865,0.4620301572474229
JJ2018_Ratio H/M normalized pP2,0.42081532939199023,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.5559396820172494,
HS2024_6_B_T3,0.555013091702184,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,0.4260091345104058,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5091399544228334,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.5814915728303547,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.5414030540378718,
DB2022_Intensity L2,,
TM2022_mock.4h.C,0.5757148686092477,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.5317372035605272,
FSO2013_Ratio M/L normalized Rep1___1,0.5102979083413116,
SAS2015_AZD/DMSO_Exp3,0.5906812729183066,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,0.5642595593381284,
EP2017_Untreated R#4 normalized log2 ratio,,
WZ2023_Pu_010_30min,0.7232420564253212,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.6405384219822128,0.4191567466953723
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.636346256343836,0.4270537678742937
JJ2018_Ratio H/L normalized___1,0.5838135032248547,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.6383135799354347,
AH2018_SILAC_MR_2_N,,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,0.5778421342259525,
MV2014_Ratio M/H normalized B3___1 (30 min),0.492219986407443,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.5818187019001637,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),0.6958504016081731,0.6415379481974409
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,0.5769172673529519,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.5576393324973192,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.5370304425921516,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.7490759767718339,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.5246031073724358,
WZ2023_Pu_005_10min,0.7322022599196674,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.5869642567251061,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.7362175428755708,
AH2018_SILAC_MR_2_X,,
HS2024_4_PD_T2,0.5411634882249936,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,0.6118995538011847
CR2017_Ratio Replicate 1.4,0.5950686815545385,
FR2021_Norm.Intensity.B,0.5533631236682811,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,0.534889622921925,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,0.5273340976913432,
CR2017_Ratio Replicate 1.3,0.5497320008192397,0.5241252560948133
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.5454308578371956,0.473114301777472
JJ2018_Ratio M/L normalized pP3,0.4607739130123073,
AH2018_SILAC_M_2_N,0.5346824886020215,0.5596874841867258
HS2024_7_PD_T2,0.5129838989506873,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,0.5524335992038225,0.6830910540651116
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.5692416421110207,
HS2024_3_B_N1,0.4963109497906064,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.7436268483379522,
CK2022_11 40-1,0.5792759303504393,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,0.5450434879641984
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,0.4368909665221204
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.7123919943940905,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5743154653171514,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.5715447797822224,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,0.5678175154515921,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.56582711237761,0.7022033493593078
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.5757224940096591,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.5560633564552062,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,0.5030481067722996,0.5893149961976327
FR2021_Norm.Intensity.H,0.47439807445404636,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.5130638133942924,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.6138454835530327,
CK2022_1 200-1,0.530672197249535,
PG2020_Intensity Mock_10h_D,0.6734537926053638,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.5003266551154446,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,
RCJD2014_5min_1,0.40341511225290383,0.3344632877458451
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,0.5137290536555096,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,0.5784321234993097,
SAS2015_PLX/AZD_Exp2,0.5611036446943575,
CR2017_Ratio Replicate 3.3,0.6380880885368361,
PG2020_Intensity 2h_C,0.6756447569577866,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.48220528300467913,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.47931223374283555,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,0.4542932739822193,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.5770269962680505,0.6854927588032319
CK2022_3 40-1,0.6036589973537319,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.5384867466117571,
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.5330731227511517,0.5433054054058534
EJN2021_5_Rest_Basal,0.5245158114146025,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.49174213241703063,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5399794458624787,0.4485479445819503
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,0.5740458963825199,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.47672613425305527,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),0.4763735870004957,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5268180246506027,
HS2024_8_I_T3,,
CF2017_EOC 3,0.5548158116440438,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.5430495671783999,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.7232842884284305,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.6036504280178598,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.6305007140721794,
KS2014_Intensity N3,0.4284294852237782,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5104878241152485,
FSO2013_Ratio H/M normalized Rep2,0.4766616291723601,
RAM2015_Log2 A,0.5080947610551925,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,0.5795930782024941,
CF2017_OSE 27,0.6071648439488331,
KS2014_Intensity E15_2,,
BS2014_Log2(Ratio H/L protein),0.512458614652438,0.512458614652438
PG2020_Intensity 8h_A,0.6502507994644279,
HS2024_7_I_T1,0.6054100001495795,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,0.6398056119447935,
SR2019_JIMT1_Biol_repl_1,0.47947856190550214,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.5548514650634864,
AH2018_SILAC_M_3_X,0.5645728947065122,0.5170558469418621
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,0.5087768301423572,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.5610507578963067,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.6351964105314498,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,
HS2024_6_B_N1,0.4848133594515331,
KBE2022_Log2_Ex_27_T,0.5808742163036206,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.5625580521425194,0.4485871145517131
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.6441929323124786,0.1477467521400693
FSO2013_Ratio M/L normalized Rep2,0.47548979408430747,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.590511210549785,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.6543282912904436,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.6873656183823948
DL2023_control-1,,
AR2021_ALG 10 μM,0.6371190968431995,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.5274054076229059,0.4292918640554617
EJN2021_4_Rest_Ins,0.5133132302910541,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.7127731657769356,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,0.5306462600570374,
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5135538311586503,0.4698505976034942
JW2021_After_3,,
GF2025_P8_Sph,0.6499011500174203,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,0.639713854265688,
AH2018_SILAC_2_N,,0.4869629140096293
CK2022_11 200-1,0.46783162364726916,
CK2022_12 200-1,0.4585948068129492,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.7185386903623985,
AH2018_TMTMS2_2_N,0.6406490901946099,0.431067547436657
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5286503734089514,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.5261606956796463,0.4959877813212517
KS2014_Intensity N4,0.4658981637368116,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,0.6459827961917651,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.5914345001737393,
CK2022_14 200-1,0.5178926169007294,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,0.5808532605571879,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5090190244033295,0.4680647033703315
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.15346061683462545,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.5306601884907332,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.6092005025406186,
GF2025_P1_Adh,0.6962623142902493,
GF2025_P1_Sph,0.45249666515027054,
EJN2021_5_Ex_Basal,0.5242865531989589,
HS2024_7_I_T3,0.4853146414953685,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.7315927126160633,
CF2017_EOC 1,0.6201556886638908,
CK2022_3 200-1,0.5362322277184552,
AH2018_LFQ_IT_3_C,,0.4911405321571888
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.6315883776074454,0.6410849011578563
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.46855396055141385,0.554118295739235
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.5426937423798125,
HS2024_5_B_T1,0.5460526875905465,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.4848483411535719,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.6057097519024383,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.5331715853726839,
JW2021_Before_2,,
TM2022_S2.12h.A,0.5728063288000946,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.6305007140721794,
AR2021_ALG 1 μM,0.5239028895452418,
HS2024_4_B_T1,0.5226096810820378,
MV2014_Ratio M/H normalized A3___1 (10 min),0.5342059298042214,0.5457936916262053
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.5187959131097493,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.5012265819931468,0.5893697804385054
CR2017_Ratio Replicate 3.2,0.5988673983983004,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5170035702987752,
CK2022_9 16-1,0.6062359404258815,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5285453511906332,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.6299725827584888,
CK2022_16 16-1,0.6020629219556375,
FS2019_db/db3,,
CK2022_15 40-1,0.5942301291647756,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),0.57353054756859,0.57353054756859
WZ2023_Su_005_10min,0.718669887294551,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.5533962577870578,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.5442362530754031
HS2024_5_PD_T3,0.539386766950229,
AH2018_TMTMS3_3_X,0.5073999916739411,0.4945648961323722
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,0.6441171790724984,0.4636243667185311
KBE2022_Log2_Ex_27_U,0.5848307470528639,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),0.45112467252499544,
AH2018_SILAC_M_1_N,0.5138912380518892,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,0.44247263265475334,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.6716103623114099,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,0.4288323171687215,
CK2022_12 16-1,0.600517991324434,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,0.5557042690746097,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.5593148408066764,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.5323766758586446,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.4862007395235007,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.5840416035451579,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.49368672126778174,
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.5368710358847828,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.6408942671808668,0.4463092441428259
GF2025_P3_Adh,0.6831251458774554,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.6403068074869331,0.398232658143906
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.6325607277997711,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,0.5558379101023183,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.5617635414397641,0.5998325445199892
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,0.5734346447201062,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,0.543531824171668,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.4763147853575127,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,0.48154603252760175,
AH2018_LFQ_1_X,0.6313675314591272,0.3636772856807563
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.4249450731463787,0.4659420032018417
FR2021_Norm.Intensity.M,0.559129174384311,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5059514183095563,
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,0.5498983827844599,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.5687490487560313,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.47412153818623615,
AR2021_KD 72h,0.5803797940561006,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.5562533651404633,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5184314796499252,0.4917943905090931
KBE2022_Log2_Ex_9_U,0.5409659872665501,
AH2018_SILAC_M_3_N,0.5279795367745549,0.4940108552303545
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,0.5683838554654266,
PG2020_Intensity Mock_10h_C,0.6791024400040436,
CF2017_OSE 29,0.5855617847832417,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,0.4882967086919485,
PG2020_Intensity 10h_A,0.6451698061188389,0.2253257245294071
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.49315470933138417,0.4592589576240856
SAS2015_PLX/AZD_Exp1,0.5511176018975559,
FR2021_Norm.Intensity.A,0.49308425330366,
FSO2013_Ratio H/M normalized Rep1___1,0.5353919415346927,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),0.6298009126214457,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.6188289224368473,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.5410704360736112,
TM2022_S2.12h.B,0.5751958080932409,
RN2012_L15,,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,0.5770217462496303,
PG2020_Intensity 4h_A,0.6542042549054636,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,0.5755621312067891,
KBE2022_Log2_Ex_24_U,0.5227831584709619,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5696838056701135,
RB2022_1_PreSprint,,
HS2024_4_I_N1,0.5671811924708638,
CK2022_7 200-1,0.5625043650625874,
CK2022_5 200-1,0.557091338011282,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,0.5459167290518208,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.5650787795185661,0.6666083233337803
AH2018_SILAC_MR_1_X,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,0.46320873867540646,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.5233452808668061,
AH2018_SILAC_3_C,0.493198100458897,0.4592174638071917
EJN2021_5_Rest_Ins,0.5366371947219843,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.5300524137919258,
CK2022_4 16-1,0.619827724213865,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.5515225329142694,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.6358801093165618,0.4254538528518833
SAS2015_PLX/DMSO_Exp1,0.570371146873152,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,0.6395383736585076,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.6460324826120392,0.5239561030479514
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,0.5848131099636713,
JJ2018_Ratio M/L normalized,0.4808210872494456,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.4659736792545139,
KBE2022_Log2_Ex_9_T,0.5533765642325322,
AH2018_SILAC_IT_2_N,0.5312767615528378,0.4513207122082523
AH2018_SILAC_IT_1_X,0.5620163803701093,0.4525794422453483
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.5522159354764664,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5396431071286668,
WZ2023_Pe_025_20min,0.758890553979777,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.6311237439340978,0.4032559877935828
HS2024_4_I_N2,0.5120763043492318,
AH2018_TMTMS2_3_N,0.631396353000662,0.4167594960934856
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.5114849398032397,
WZ2023_Su_005_30min,0.7423842830253665,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5179626726929316,
WZ2023_Su_025_10min,0.7267902967674942,
AH2018_LFQ_IT_4_X,0.5453210058725357,0.4729253157721822
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.7202823115000683,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.563933554409514,0.4961647468605703
MV2014_Ratio H/M normalized A2___1 (2 min),0.5011082745099587,
PG2020_Intensity 8h_D,0.643102041476163,
LY2019_P7+,0.5425932511580894,
EP2017_Untreated R#1 normalized log2 ratio,,
RN2012_L10,,
PG2020_Intensity 4h_C,0.6589290935397099,
EP2017_Mitotic R#3 normalized log2 ratio,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.5163563423243654,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.562287053934291,0.4945660217096561
HS2024_4_B_T3,0.46864374941757203,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.5595981622313132,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,0.5796888957331716,
HS2024_8_I_T2,0.5740767845396919,
KBE2022_Log2_Ex_6_U,0.5691663626286094,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5801773710983169,0.5894059322401777
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,0.552242638852676,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5163611359005262,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,
GF2025_P9_Sph,0.5794074455765557,
CK2022_6 200-1,0.5542590289069937,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.5165225725786476,0.5535663481027472
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,0.5211714187439397,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.4589878044480622,
SAS2015_AZD/DMSO_Exp1,0.5880842858770262,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,0.4727443382136781,
HS2024_3_B_T3,0.5695551794374938,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,0.639061861089145,
PG2020_Intensity 2h_D,0.6733989447491138,
EP2017_Untreated R#3 normalized log2 ratio,,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5551100670909743,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5073035015212493,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,0.5790181678703396,
JJ2018_Ratio H/L normalized pP1,0.41911531652536593,
EP2017_Pervanadate R#2 normalized log2 ratio,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,0.5719683634200433,
AH2018_SILAC_2_C,,0.4910062287109331
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.5262143085415338,
KBE2022_Log2_Ex_29_T,0.5598442719657051,
HS2024_7_I_T2,0.47505792149710785,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.5474587729169269,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,0.6083579305318205,
EJN2021_1_Ex_Basal,0.5224009186523008,
FR2021_Intensity.M,0.559129174384311,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.6176161295692731,
PG2020_Intensity CT_C,0.6728986778837016,
ZCP2016_Ratio H/L Rep 1,0.5971754218568301,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.5655571577563692,
EP2017_Untreated R#3 log2 ratio,,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.49953395448129495,
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,0.5089736738875974,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,0.5537958299683958,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.553019370446423,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.5738478576344752,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,0.500556624439076,0.3344920889644463
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.46785673005123085,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.6489198886468177,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.4063605217283599,
HS2024_3_PD_T3,0.4939149271258153,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,0.5266064646708881,
RAM2015_Log2 C,0.5042022178535116,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.640826753994855,0.4490604994439763
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,0.6120063163096353,
RAM2015_Log2 B,0.5139855509826254,
YP2020_Intensity C10_R1_mult_log2,0.517074822773081,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.5137035622037484,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,0.6170411442518857,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.5384908810751838,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,0.3853715973724316
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.5335879309491561,
PG2020_Intensity Mock_10h_B,0.4491281602622461,
WZ2023_Su_025_30min,0.7362962508595796,
AH2018_LFQ_4_N,0.6377130293913913,
CR2017_Ratio Replicate 1.2,0.6446197643299367,0.6964335600095324
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.5042316984125756,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,0.517297941924984,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.5986280815139705,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.4513334590140671,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,0.5005174186211321,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),0.5601075935525028,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.4956808261976342,0.4540926961009539
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5787833242421438,0.5796243282774973
RM2024_Intensity D0-1,,0.4697331476701242
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,0.4246353790374665,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.46855092119290254,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,0.5785516905611985,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.5446432152963547,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.6464573296051739,0.4924142181390691
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.6395161668464744,
AH2018_LFQ_2_X,0.6410492978614868,
PG2020_Intensity 2h_B,0.6822564827863261,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,,
GF2025_P3_Sph,0.5628473558910198,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),0.4622236250913503,
AH2018_SILAC_1_C,0.5172238858489215,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.48471611236681456,0.4390759170896839
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,0.48438894183902104,
CR2017_Ratio Replicate 2.4,0.5077402750673512,
ZQ2022_N1,,
LY2019_P6-,0.5882174969884342,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,0.6286657405591443,0.3723607695641872
RKK2015_TNF-α/IKKb,0.4308435582704558,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,0.5500571697790924,
JJ2018_Ratio H/L normalized pP3,0.578918190932171,
CK2022_7 40-1,0.6238278015662995,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.6693311734073759,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,0.5839132561575411,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,0.5439724875356721,
WZ2023_Su_025_20min,0.7252380127744599,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,0.47497192750270567,
LY2019_P8-,0.5065310558443724,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,0.5714904101189741,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.5916798650649469,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,0.6395108833624328,0.3424272699434325
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.4844172179340883,
EJN2021_4_Ex_Ins,0.5562630597197932,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.5403606144940105,
EP2017_Pervanadate R#3 log2 ratio,,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.6044169349595983,0.5164261469283539
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,
AH2018_LFQ_M_4_C,,0.7075178241771065
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,0.5712052455629607,
RN2012_H04,,
CK2022_6 40-1,0.6186364859613286,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.5641292103657656,
LY2019_P3-,0.5343949786918638,
FR2021_Intensity.A,0.4761910696152911,
EJN2021_3_Ex_Ins,0.5601887538088128,
MV2014_Ratio M/L normalized A1___1 (2 min),0.5398426141207213,
WZ2023_Pe_005_30min,0.7594688290597993,
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,0.5273338679261584,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.4072323549964061,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.7271821716966294,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.4825628744621383,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,0.4546228822956544,
HS2024_5_B_N1,0.5451104540260973,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.6397440599941017,0.4027351348642018
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5093431649233588,0.4485965065236718
HS2024_8_I_N2,0.5121327369036083,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5250021053374127,
LY2019_P8+,0.5309687635676493,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,0.4151620474621509,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.6453316843503999,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,0.48077966856191595,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.5568434631355972,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.5785662812770159,
LY2019_P2-,0.5423321228571563,
AH2018_LFQ_IT_1_X,0.5145572708455497,
JJ2018_Ratio H/L normalized pP3___1,0.5790625301262926,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.7613679670538032,
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.5336931848458942,0.6009249013579292
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,0.5626524660402502,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.6053533061379732,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.6108909566083429,
HS2024_5_B_T2,0.5539049046354372,
HS2024_6_I_T1,0.49750120323991154,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,0.4396359371573458,
KBE2022_Log2_Ex_36_U,0.5954854274921302,
AH2018_TMTMS3_3_N,0.5185982815424272,0.4665089460804535
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,0.45460740933791366,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,
KBE2022_Log2_Ex_36_T,0.5910736895831983,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.7210668923455039,
KS2014_Intensity C2,0.6108671768606091,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,0.5738015356005405
KBE2022_Log2_Ex_42_T,0.5568596916128823,
CK2022_9 200-1,0.46485727026880364,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.46637178473600094,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.591132959604877,
RBK2021_1332T Late,,
LY2019_P1-,0.5050357234570058,
RKK2015_TNF-α/basal.1,0.46185764618062436,
RKK2015_TNF-α/TNF-α+SC-514,0.3494815321364392,
CR2017_Ratio Replicate 2.5,0.49416201252720726,
HS2024_3_I_T3,0.5016080584677316,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,0.5616619638633513,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,0.5416066854831101,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.5651390345523817,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,
RKK2015_SC-514/basal,0.44190371052397887,0.653269230767723
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.7214818547745259,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,0.5739045567404093,
HS2024_5_I_T3,,
KS2014_Intensity N1,,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,0.5801915558983974,
CR2017_Ratio Replicate 1,0.5365128249660938,0.4939946332519409
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,0.559916888053127,
JJ2018_Ratio H/M normalized pP3,0.6180578245585455,
AH2018_SILAC_MR_2_C,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.32859351447454915,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,
JJ2018_Ratio H/M normalized___1,0.4374379448704327,
RCJD2014_15min_2,0.4593547006966636,0.7094003846819935
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,0.5058736472385557,
HS2024_5_I_N1,0.49923243363825803,
HS2024_6_I_N1,0.4450863122621862,
AR2021_KD 48h,0.5636361074838131,
FR2021_Intensity.B,0.5533453739011294,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.747844051975433,
KBE2022_Log2_Ex_29_U,0.5599730564926759,
HS2024_7_B_T1,0.5380086669861193,
AH2018_LFQ_M_2_X,0.6511566953864698,
AH2018_LFQ_IT_4_N,0.5398514092875567,0.4486148834625568
CK2022_15 200-1,0.5239743246010423,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.4400642074293556,
JJ2018_Ratio M/L normalized pP3___1,0.46048728564172314,
KBE2022_Log2_Ex_34_T,0.5215893069679183,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,0.5543804742568778,
LY2019_P2+,0.5842489210537112,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.5223419985051466,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),0.502818018249615,0.5213019029680375
WZ2023_Su_010_30min,0.6941837126172585,
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.5149808447898359,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,0.5748514882943055,
EP2017_Pervanadate R#1 normalized log2 ratio,,
HS2024_8_B_T3,0.5283359317272935,
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,0.5526634847877763,
WZ2023_Pe_010_20min,0.7548709743953246,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.4821655175135108,0.601186867310454
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.4718584947500787,0.3573544075608466
KS2014_Intensity C1,0.598710034923217,0.6140779079933607
FSO2013_Ratio H/M normalized Rep3___1,0.4753041693013582,
AH2018_SILAC_M_3_C,0.5135164246080971,0.5002800671272905
RKK2015_TNF-α+IKKb/TNF-α,0.6086506467217981,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.4848577169886604,0.5651415095932389
AH2018_SILAC_M_2_X,0.541224910480347,0.5847098959270886
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.5715775426260856,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.7197281217917453,
PG2020_Intensity 6h_C,0.6409537475576543,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,0.4829239671325479,
AH2018_LFQ_M_3_N,0.638436370877536,0.4214043390911128
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.6349605353895342,0.4055541462785813
CK2022_15 16-1,0.605515916704923,
CK2022_3 16-1,0.6170589854756009,
LY2019_P4-,0.4935677884764862,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.5120143760026596,
GF2025_P8_Adh,0.5443853783571342,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,0.5134338615277174,
GF2025_P5_Sph,0.5077448771822402,
CK2022_10 16-1,0.6032930767054632,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,0.5900234466182499,
IMM2018_normalised rep. int. CDK5L-1,0.4836820781549326,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,
EJN2021_2_Ex_Basal,0.5384495831195812,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.6148418375251997,
AR2021_L41 10 μM,0.5411196484398464,
CF2017_EOC 2,0.5353885139029999,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.5106914104574407,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.4786030495424102,
CK2022_6 16-1,0.6286754324317547,
ZX2022_CB treated Replicate 1,0.5430983712856766,
BS2014_Log2(Ratio H/L normalized Rep_3),0.6942278464542615,
TM2022_mock.12h.C,0.5805244178182496,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.6437001742579584,0.4182818165341486
AR2021_L41 1 μM,0.5297756665620386,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.6429814547555311,0.4144804916250284
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.5890133906814633,
KS2014_Intensity C4,0.5726354296102176,0.4693388121238515
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.5514288890198815,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.5498010869107579,0.4603648234508861
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,0.5506046258648034,
SAS2015_PLX/DMSO_Exp3,0.5743195537483226,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.5659910070805956,0.7016179866132943
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,0.5695187503747214,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.5022056043567688,0.4656852230502029
WZ2023_Pu_025_10min,0.7305284317835484,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,0.7237138127404596,0.6578503032106001
FSO2013_Ratio M/L normalized Rep3___1,0.49910612392129655,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,0.5178826231065816,
ZCP2016_Ratio H/L Rep 2,0.5860259380975611,
CF2017_EOC 4,0.555454951240586,
JJ2018_Ratio H/L normalized pP1___1,0.4121633245499542,
WZ2023_Pe_010_30min,0.7501813059765519,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.4867000523671869
KS2014_Intensity C6,0.5141792230184248,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.5783102317902141,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.5335028789021785,
JJ2018_Ratio H/M normalized pP1,0.438983113864162,
CK2022_16 40-1,0.5910219321431589,
AH2018_SILAC_IT_2_C,0.5063070268004318,0.4933698962052226
CK2022_5 40-1,0.6204610315490839,
AH2018_LFQ_3_X,0.6317493957484388,
UK2020_UA_3,,
LY2019_P7-,0.5171816630511459,
GF2025_P5_Adh,0.7143277453962216,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.49239374545120945,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),0.5185536306703833,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.6013412364161229,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5351255074227219,
PG2020_Intensity CT_B,0.6745475230256721,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.5565230151351629,0.5876961304885867
AH2018_LFQ_3_C,,0.6807960022164417
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.6411993802143815,
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.5163874097599227,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.5275753770061195,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,0.48007481513113165,
FR2021_Intensity.H,0.47439807445404636,
CK2022_14 16-1,0.5984088604082106,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),0.5565407769644725,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,0.42517841098667886,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,
AH2018_TMTMS2_1_X,0.6525476517756218,0.4281158948465546
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,0.5244353797416328,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.5605102894015604,
HS2024_6_I_N2,0.4702619002329243,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,0.577572743520911,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.5389566882851794,0.3725936865663119
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.6074188604920348,
HS2024_4_I_T3,0.5204640270634732,
AH2018_SILAC_1_X,0.5146151251852762,
PG2020_Intensity 10h_B,0.6371908393182285,0.2776879643935802
AH2018_TMTMS3_1_X,0.5117852950002181,0.5127587793109607
CF2017_FTE 14,0.56142638962117,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,0.5159211016440757,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.6272309222557655,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.5390359586011126,
HS2024_5_I_N2,0.547182503586559,
SAS2015_PLX/AZD_Exp3,0.5420352461907897,
EP2017_Pervanadate R#2 log2 ratio,,
AS2011_Ratio H/L Normalized RNAi_2_1,,
